NCT07685327 Comparing Mixed Reality and Physical Therapy to Improve Balance and Coordination in Adolescents With Spastic Diplegic Cerebral Palsy
| NCT ID | NCT07685327 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ibadat International University, Islamabad |
| Condition | Cerebral Palsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-01-12 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-01-12 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial aims to compare the effectiveness of fully immersive Mixed Reality (MR) combined with standard physical therapy versus standard physical therapy alone in improving balance and coordination among adolescents with spastic diplegic cerebral palsy. A total of 40 participants aged 10 to 19 years will be randomly assigned to one of two treatment groups. The intervention will be provided three times per week for eight weeks. Balance and coordination will be assessed before treatment, at four weeks, and after completion of the intervention using validated clinical outcome measures. The findings of this study may help determine whether immersive Mixed Reality can enhance rehabilitation outcomes in adolescents with cerebral palsy.
Eligibility Criteria
Inclusion Criteria: * Male and female participants. * Adolescents aged 10 to 19 years. * Clinically diagnosed with spastic diplegic cerebral palsy. * Gross Motor Function Classification System (GMFCS) Levels I, II, or III. * Pediatric Balance Scale (PBS) score greater than 35. * Willing to participate in the study and provide written informed consent/assent with parental or legal guardian consent where applicable. Exclusion Criteria: * Cognitive impairment (MMSE score \<24). * History of seizure disorders. * Visual or hearing impairment that interferes with participation. * Diagnosed psychological or psychiatric disorders. * Any other medical condition that would prevent safe participation in the study.
Contact & Investigator
Muhammad Yaseen Khattak, MS-PPT
PRINCIPAL INVESTIGATOR
Ibadat International University, Islamabad
Frequently Asked Questions
Who can join the NCT07685327 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 19 Years, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07685327 currently recruiting?
Yes, NCT07685327 is actively recruiting participants. Contact the research team at Ashar.rafi@uipt.iiui.edu.pk for enrollment information.
Where is the NCT07685327 trial being conducted?
This trial is being conducted at Mansehra, Pakistan.
Who is sponsoring the NCT07685327 clinical trial?
NCT07685327 is sponsored by Ibadat International University, Islamabad. The principal investigator is Muhammad Yaseen Khattak, MS-PPT at Ibadat International University, Islamabad. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.